We conclude that 5'-nucleotidase is a n example of a membrane enzyme which displays a biphasic Arrhenius plot independent of its lipid environment.
Previous work from this laboratory has demonstrated the presence of two carrier mechanisms for the transport of pyruvate and lactate across the erythrocyte membrane, both being inhibited by a-cyano-4-hydroxycinnamate and one, identified as the well-characterized CI-carrier, inhibited by isothiocyanostilbene derivatives (Halestrap, 1976) . Evidence has been presented for the existence of a transport mechanism for pyruvate and lactate in Ehrlich ascites cells which is inhibited by a-cyanocinnamate derivatives and, more powerfully, by thiol reagents such as mersalyl (Spencer & Lehninger, 1976) . It seemed likely that the carrier of the ascites cell might be identical with the C1--independent carrier of the erythrocyte. To test this possibility the effects of thiol reagents on pyruvate and lactate transport into the erythrocyte have been studied and the kinetics of the CIF-independent transport process studied in more detail. Evidence is presented that shows that this carrier is sensitive to thiol reagents such as mersalyl and, more specifically, p-chloromercuribenzenesulphonate. Similar conclusions have been reached, in part, by Deuticke et a/. (1978) . The properties of this carrier suggest it is similar to that present in ascites cells and experiments on other tissues suggest that it is the normal plasma-membrane transport mechanism for pyruvate and lactate. A summary of some of this work has been presented previously (Halestrap, 1978) .
In these studies pyruvate and lactate transport across the erythrocyte membrane have been studied by three methods. In all cases 4-acetamido-4'-isothiocyanatostilbene-2,2'-disulphonate (0.1 mM) was present to inhibit totally the C1--dependent transport mechanism (Halestrap, 1976) . Firstly the loss of lactate from cells previously loaded with L-lactate by metabolism of glucose was investigated as described by Halestrap (1976) . Even in the absence of added exchangeable ions to the cells, lactate efflux occurred which was inhibited by mersalyl. Thus at 10°C the loss of lactate from preloaded cells in 3 min decreased from a control value of 1.38 f0.045 nniol/pl of intracellular space to 0.16+0.058 in the presence of 2m~-mersalyl (values given as means+s.E.M. for two observations). Subsequent addition of 10mwpyruvate led to further loss of lactate from the cells. Thus in Smin the additional efflux was 1.05+0.08 and 0.095 k0.078 nmol/pl of intracellular space for control and mersalyl-treated cells respectively (values are the means? S.E.M. for four observations).
Secondly the proton flux associated with pyruvate and lactate transport was studied by using a recording pH-meter as described by Halestrap (1975 Halestrap ( , 1976 and Spencer & Lehninger (1976) . It should be noted that previous work from this laboratory has failed to demonstrate proton movement associated with pyruvate entry into the cell (Halestrap, 1976) . This was found to be due to two interrelated factors. Firstly, the net uptake of pyruvate is very much slower than pyruvate/lactate exchange and secondly in earlier experiments outdated blood was used in which some endogenous lactate was present, allowing the exchange transport to occur. Details of the kinetic parameters obtained by proton-flux measurements are shown in Table 1 . All proton flux associated with the transport of pyruvate was blocked by 100pM-pchloromercuribenzenesulphonate, whereas that of acetate was unaffected. Proton flux accompanying L-and D-lactate transport was also totally inhibited by this reagent, except at high substrate concentrations (greater than 5 m~) or below pH 7. Under these conditions some transport occurred which was inhibitor-insensitive and this was assumed to be due to free diffusion of the undissociated acids. The third method used was the 'inhibitor stop' method described by Halestrap (1976) but modified as follows. Firstly mersalyl(2m~) was used as well as 2 m~-cc-cyano-4-hydroxycinnamate to stop transport, and secondly two different media were used for transport studies. In some experiments Recently outdated human blood was preincubated in citrate buffer (84 mM-sodium citrate/lOmM-Tris, adjusted to pH 7.4 with NaH,P04, containing0.1 m~-4-acetamido-4'-isothiocyanatostilbene-2,2'-disulphonate) at 12 % haematocrit and 10°C with mersalyl (A) or p-chloromercuribenzenesulphonate (m) as indicated. Pyruvate uptake was measured radioactively as described by Halestrap (1 976) at a pyruvate concentration of 0.5 mM, uptake being terminated after 2min by addition of 2m~-ct-cyano-4-hydroxycinnamate and 2 m~-mersalyl. Values represent the means of two observations expressed as percentages of the control rate of uptake (0.370nmol/min per ml of intracellular space).
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---0.5 ) the citrate medium described by Halestrap (1976) was used, since this generated a pH gradient (alkaline inside) which aided pyruvate and lactate accumulation. In other experiments buffered saline was used as described by Spencer & Lehninger (1976) in order to resemble the physiological situation more closely. Details of the conditions are given in the legends to the Figure and Table. In Fig. 1 the inhibition of pyruvate transport by mersalyl and p-chloromercuribenzenesulphonate is demonstrated; similar results were obtained when L-lactate was the substrate for transport. Both reagents are potent inhibitors of pyruvate transport, p-chloromercuribenzenesulphonate being the more powerful. The inhibition by mersalyl appears to be similar to that observed by Spencer & Lehninger (1976) for ascites cells, although the inhibitor is more potent in the erythrocyte. This may reflect the higher pH (7.4) used in the present studies. The inhibition by p-chloromercuribenzenesulphonate is similar to that observed by Deuticke et al. (1978) in human erythrocytes. Table 1 shows that under similar conditions to those used by Halestrap (1976) , similar kinetic constants were obtained. Thus the presence of 4-acetamide-4'-isothiocyanato-
